Key facts
- China's 'Beinao No. 1' semi-invasive brain-computer interface (BCI) system has completed 16 implantations.
- The 'Beinao No. 1' system is expected to be piloted nationwide in qualified Grade-A tertiary hospitals in 2027.
- 'Beinao No. 2' is set to begin clinical validation.
Following the approval of the invasive NEO BCI, China continues to advance its brain-computer interface technology. The 'Beinao No. 1' system, a semi-invasive BCI, has reached a significant milestone with 16 successful implantations. This progress indicates China's ongoing commitment to developing and deploying BCI technology for medical applications, with plans for wider clinical trials and eventual nationwide adoption.